The nomograms to predict early death among metastatic small-cell lung cancer patients: a retrospective study based on SEER database

Tao, Hai; Zhou, Lin; Wang, Jingqiu; Wu, Hao; Wang, Yishun; Tian, Tian; Wu, Wangchun; Mei, Ting

doi:10.21037/tcr-22-462

Cited by 2 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous studies have investigated early mortality in malignancies such as gastric, colorectal and ovarian cancers [27][28][29][30][31][32] and identified relevant risk factors. Prognostic factors in patients with metastatic SCLC have also been explored, [33][34][35] but fewer studies have been conducted on early death in elderly SCLC patients.…”

Section: Discussionmentioning

confidence: 99%

A practical nomogram for predicting early death in elderly small cell lung cancer patients: A SEER-based study

Chen,

Liu,

Tou

et al. 2024

Medicine

View full text Add to dashboard Cite

This study aimed to identify risk factors for early death in elderly small cell lung cancer (SCLC) patients and develop nomogram prediction models for all-cause and cancer-specific early death to improve patient management. Data of elderly patients diagnosed with SCLC were extracted from the SEER database, then randomly divided into training and validation cohorts. Univariate and stepwise multivariable Logistic regression analyses were performed on the training cohort to identify independent risk factors for early death in these patients. Nomograms were developed based on these factors to predict the overall risk of early death. The efficacy of the nomograms was validated using various methods, including ROC analysis, calibration curves, DCA, NRI, and IDI. Among 2077 elderly SCLC patients, 773 died within 3 months, 713 due to cancer-specific causes. Older age, higher AJCC staging, brain metastases, and lack of surgery, chemotherapy, or radiotherapy increase the risk of all-cause early death, while higher AJCC staging, brain metastases, lung metastases, and lack of surgery, chemotherapy, or radiotherapy increase the risk of cancer-specific death (P < .05). These identified factors were used to construct 2 nomograms to predict the risk of early death. The ROC indicated that the nomograms performed well in predicting both all-cause early death (AUC = 0.823 in the training cohort and AUC = 0.843 in the validation cohort) and cancer-specific early death (AUC = 0.814 in the training cohort and AUC = 0.841 in the validation cohort). The results of calibration curves, DCAs, NRI and IDI also showed that the 2 sets of nomograms had good predictive power and clinical utility and were superior to the commonly used TNM staging system. The nomogram prediction models constructed in this study can effectively assist clinicians in predicting the risk of early death in elderly SCLC patients, and can also help physicians screen patients at higher risk and develop personalized treatment plans for them.

show abstract